Hospital Board Member Eleanor Beaumont Demanded Her Daughter-in-Law End Her Comatose Son's Life — But Dr. Evelyn Reed Knew the Truth
Isabella’s relentless digging continued to yield critical information. Her contacts were proving invaluable, navigating the shadowy world of offshore finance and defunct medical research firms with an impressive tenacity. My suspension left me with more time, a double-edged sword that allowed me to support her investigation while gnawing at my professional identity.
Then, one evening, Isabella called again, her voice hushed and excited. “Evelyn, you won’t believe what my contact found.”
“Tell me,” I urged, my heart pounding. Every call from Isabella now felt like a step closer to the precipice.
“Remember that Swiss research firm? ‘GenX Solutions,’ the one where Dad’s million dollars went?” she asked.
“Yes,” I confirmed, picturing the records Isabella had shown me. “The one that folded after a scandal.”
“My contact managed to track down that junior researcher, Dr. Elias Thorne. He was willing to talk, for a price, and with a guarantee of anonymity,” Isabella explained. “He had kept copies of everything, encrypted. He was terrified of Eleanor even after all these years.”
Dr. Elias Thorne. A tangible connection to the past. The mention of his fear of Eleanor sent a chill down my spine. It underscored just how ruthless she had been, and how far her influence extended.
“What did he reveal?” I asked, barely daring to breathe.
“GenX Solutions was running an experimental drug trial,” Isabella began, her voice gaining a horrified edge. “Targeting a very specific, very rare genetic marker for familial neurological atrophy. Subtype Beta-9.”
My blood ran cold. Subtype Beta-9. The exact genetic marker for Thomas’s condition. The same one found in his suppressed teenage genetic test, and likely the one that afflicted his father, Charles. Eleanor’s ghost fund hadn’t just gone to a generic experimental firm; it had gone to a firm specifically researching *their* family’s secret disease.
“Eleanor Beaumont was the sole private investor,” Isabella continued, the disgust evident in her tone. “She funnelled over a million dollars into that trial. Thorne said it was highly unorthodox; she dictated many of the parameters, pushed for rapid results.”
The scale of her manipulation was staggering. Eleanor wasn’t just hiding a condition; she was actively, personally funding a risky, experimental treatment for it decades ago, using her husband’s money. This was not concern; this was an investment.
“What happened to the trial?” I asked, dreading the answer.
“It was a disaster,” Isabella revealed, her voice grim. “Dr. Thorne provided documents. The drug was highly unstable, caused severe adverse reactions. Accelerated neurological decline in several patients. Permanent damage. There were even a couple of patient deaths directly attributed to the trial’s complications.”
A wave of nausea washed over me. Patient deaths. Permanent damage. Eleanor had personally funded an unethical experiment that harmed and killed people, all in a desperate attempt to conquer the genetic condition that plagued her family. And she had swept it all under the rug.
“The ‘scandal’ was a cover-up,” Isabella confirmed. “Eleanor used her influence, and her money, to buy off regulators and silence the families. GenX Solutions was quietly dissolved, and the research was buried. Dr. Thorne said he was threatened, told to keep silent or face ruin.”
The personal cruelty of this act was immense. Not only had Eleanor put her own son at risk by suppressing his diagnosis, but she had directly caused harm to others through her reckless ambition. Her obsession with control and appearances extended to the lives of strangers, all for the sake of her family’s “perfect” image and, undoubtedly, her financial investment.
“And she wanted rapid results,” I murmured, recalling Isabella’s earlier comment. “That would explain the unethical nature, the shortcuts.”
“Exactly,” Isabella agreed. “Thorne said she was obsessed with finding a ‘cure’ for Beta-9, almost as if she was racing against time. He believes she was worried about Thomas already, even then.”
My mind raced. Eleanor’s current push for Thomas to undergo a dangerous, experimental procedure, her willingness to forge documents and cut off his standard care, all converged on this dark revelation. It wasn’t just a coincidence.
“This new procedure she’s pushing for Thomas,” I said, feeling a sickening certainty. “It’s the same trial, isn’t it? A modified version of the GenX Solutions drug?”
Isabella was silent for a moment, then let out a shaky breath. “Thorne mentioned that Eleanor was insistent on retaining all the original research data, even after GenX dissolved. He suspected she planned to revive it, once the heat died down, or if the need arose.”
The truth was a cold, hard slap. Eleanor wasn’t a grieving mother seeking a cure; she was a desperate investor trying to recoup a million-dollar loss and resurrect a failed, unethical experiment, using her comatose son as the test subject. This was not a rescue mission; it was a desperate gamble.
“She’s trying to salvage her past investment,” I stated, the words tasting like ash in my mouth. “And protect her reputation. Thomas is just a means to an end for her.”
“It’s beyond cruel, Evelyn,” Isabella whispered. “To put him through something that already failed, that already harmed people.”
The moral depravity of Eleanor’s actions was staggering. She had knowingly put her own son in harm’s way, gambling with his life, not out of love, but out of financial desperation and a ruthless need to control the narrative of her family’s legacy.
“We have to stop her,” I said, my voice filled with a fierce, cold resolve. “This is not just a medical error; it’s a crime against Thomas, and against all those who suffered in her first trial.”
Isabella promised to secure a sworn affidavit from Dr. Thorne, complete with the encrypted documents detailing the GenX Solutions disaster. This was no longer just a familial squabble; it was a matter of public safety, a deep-seated corruption that needed to be brought to light.
The revelation of Eleanor’s experimental past, her direct involvement in a failed and unethical drug trial, transformed our fight. She wasn’t just a powerful, domineering mother-in-law; she was a dangerous, morally bankrupt manipulator, willing to sacrifice lives for her own gain and image. And her son was now her unwilling subject.
More Stories
+ There are no comments
Add yours